The global transcranial magnetic stimulator market size is expected to reach USD 2.1 billion by 2026 and growing at a CAGR 9.0% from period 2019 to 2026.
LOS ANGELES, July 25, 2019 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026”.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1542
Rising incident of the various neurological diseases, rising patient population, rising number of premature birth suffering from neurological diseases and changing lifestyle have driven the growth of the transcranial magnetic stimulator market across the globe. A number of government and private organization are conducting various surveys and seminar to educate the people which has led to increase the demand of transcranial magnetic stimulator, thereby driving the transcranial magnetic stimulators market growth.
Metal and neurological disorder is becoming common issues across the globe due to rapidly changing lifestyle and increased life expectancy. However, there are several medical factors directly influencing the growth of the transcranial magnetic stimulator market. Neurological disorders are the leading cause of death and disability in the world today. In 2015, they ranked as the leading cause group of DALYs (disability adjusted life years), comprising 10.2% of global DALYs, and the second-leading cause group of deaths, comprising 16.8% of global deaths. As per our analysis, in 2015, the most prevalent neurological disorders were tension-type headaches (about 1,500 million cases), migraine (about 1,000 million), medication overuse headaches (about 60 million), and Alzheimer's disease and other dementias (about 46 million cases). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36.7 percent, and the number of DALYs by 7.4 percent. As per the World Health, increasing patient population suffering from organization multiple sclerosis, cerebrovascular, Parkinson’s, epilepsy, and Alzheimer’s offering wide scope for transcranial magnetic stimulator. Increasing Burgan of mortality from neurological diseases is rising and is one the key factor driving the sales of transcranial magnetic stimulator. Due to rising work life and growing stress incidences there has been significant rise has been seen in patient suffering from depression resulting into developing demand for transcranial magnetic stimulator. Medical causes of neurological disorder includes congenital abnormalities or disorders, infections, lifestyle or environmental health problems including malnutrition, and brain injury, spinal cord injury or nerve injury. However, as per the International Journal of Epidemiology, genetic disorder is the common cause observed for neurological disorder across the different geographies of the globe.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/transcranial-magnetic-stimulator-market
The transcranial magnetic stimulator is segmented by type and application. On the basis of type, the global transcranial magnetic stimulator is segmented into dTMS, rTMS, and others.
On the basis of application, the market is segmented into depression, and epilepsy.
Geographically, the Transcranial magnetic stimulator market is segmented into Asia Pacific, North America, Europe, and Latin America & Middle East Africa (LAMEA).
Geographically, the global transcranial magnetic stimulator market is evaluated across America, Europe, Asia-Pacific, and the Middle East, and Africa. Americas is the largest region for transcranial magnetic stimulator market and has acquired around 40% of the global market share. After Americas, Europe is the second largest region with 30% global market shares in 2017. However, Asia Pacific anticipated witnessing largest growth rate.
Increasing prevalence of neurological diseases across North as well as South America is the primary reason behind significant growth of this region. Rapid life style changes, technological improvements, developed healthcare infrastructure, are some of the other factors indirectly impacting the growth of this region. Americas further expected to continue its dominance as large number of neurological disorder cases are registered in North America.
Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases
Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs
Europe, on the other hand, is the second largest market witnessing moderate growth for transcranial magnetic stimulator market. European government is coming up with some of the initiative to educate and to raise the awareness regarding the neurological diseases. One of the initiatives such as European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall transcranial magnetic stimulator market. Europe acquired overall 30% global market share in 2017.
Asia Pacific anticipated growing at fastest CAGR during the forecast period. Growing healthcare tourism, growing prevalence of chronic diseases, changing lifestyle, heavy investment in transcranial magnetic stimulator and large number product launches are some of the primary factors supporting the growth of this region. Apart from this, growing healthcare infrastructure, and technological awareness and leverage set to offer productive regional growth.
Some of the major players analyzed and profiles in this market include Brainsway Ltd., Nexstim Plc, Magstim, Neuronetics Inc., TMS Neurosolutions, Mag Venture, and eNeura Inc..
Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here
Request for Customization @ https://www.acumenresearchandconsulting.com/request-customization/1542
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1542
If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135
For Latest Update Follow Us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting/